Arkolith/Insider Trading/RSLS/Form 4

Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Sep 17, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$140K
Net Open-Market Flow
-$140K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2021Sell(S)48K$2.89$140K358K
Jul 22, 2021Grant(A)90K—$0406K
Jul 22, 2021Grant(A)282K—$0316K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001790300-21-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML